AUR101

DRUG2 trials

Sponsors

Aurigene Discovery Technologies Limited

Conditions

Chronic Plaque-type PsoriasisPlaque Psoriasis

Phase 2

A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis

CompletedNCT04207801

Aurigene Discovery Technologies LimitedChronic Plaque-type Psoriasis

Start: 2020-01-21End: 2021-04-15Updated: 2023-08-14

A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3)

CompletedNCT04855721

Aurigene Discovery Technologies LimitedPlaque Psoriasis

Start: 2021-05-04End: 2022-12-10Updated: 2022-12-13